1. Home
  2. GUT vs YDES Comparison

GUT vs YDES Comparison

Compare GUT & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Utility Trust (The)

GUT

Gabelli Utility Trust (The)

HOLD

Current Price

$6.59

Market Cap

555.5M

Sector

Finance

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$2.40

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GUT
YDES
Founded
1999
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
555.5M
543.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GUT
YDES
Price
$6.59
$2.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
249.0K
35.0K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
10.93%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.42
$2.14
52 Week High
$6.70
$25.00

Technical Indicators

Market Signals
Indicator
GUT
YDES
Relative Strength Index (RSI) 65.15 31.96
Support Level $6.09 $2.14
Resistance Level $6.70 $5.36
Average True Range (ATR) 0.09 0.43
MACD 0.02 0.03
Stochastic Oscillator 69.77 10.61

Price Performance

Historical Comparison
GUT
YDES

About GUT Gabelli Utility Trust (The)

Gabelli Utility Trust operates as a diversified closed-end investment management company. The fund's primary objective is the long-term growth of capital and income. To achieve its objective, the fund may invest its assets in common stocks and other securities of foreign and domestic companies involved in providing products, services, or equipment for the generation or distribution of electricity, gas, & water; and telecommunications services or infrastructure operations. It invests in various sectors, of which Electric Integrated, Water, Telecommunications, and U.S. Government Obligations and others.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: